Semglee® (insulin glargine-yfgn) – First interchangeable biosimilar launch
November 6, 2021, , Viatris launched Semglee (insulin glargine-yfgn) and insulin glargine-yfgn, the first interchangeable biosimilars to Sanofi’s Lantus® (insulin glargine).
Download PDF
